StonvexLoading…
StonvexStonvexStonvexCore line items from CPNG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $8.50B | $34.53B | $25.70B | $16.43B |
Operating Income | $-242.00M | $473.00M | $465.00M | $303.00M |
Net Income | $-266.00M | $208.00M | $234.00M | $139.00M |
EPS (Diluted) | $-0.15 | $0.11 | $0.13 | $0.08 |
Total Assets | $17.40B | $17.79B | $18.67B | $17.83B |
Total Liabilities | $13.47B | $13.16B | $13.93B | $13.15B |
Cash & Equivalents | $6.30B | $6.32B | $7.23B | $6.80B |
Free Cash Flow OCF − CapEx | $-112.00M | $522.00M | $800.00M | $361.00M |
Shares Outstanding | 1.82B | 1.85B | 1.85B | 1.85B |